Roche Official: Leukemia, p53 Microarrays Next on the Agenda | GenomeWeb

SAN DIEGO, Feb. 22 (GenomeWeb News) - Following a talk at the Clinical Genomics conference here last week, Walter Koch, senior director of Roche's pharmacogenomics department, provided a few details concerning the company's upcoming leukemia microarray and p53 AmpliChip products, which are being produced using technology the company licensed from Affymetrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.